Clinical Trial Update: Inotuzumab Ozogamicin and Conventional Chemotherapy In Patients Aged 56 Years and Older With ALL [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating inotuzumab ozogamicin with conventional chemotherapy in adults 56 and older with precursor cell lymphoblastic leukemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Acute Lymphoblastic Leukemia
• Precursor B-cell Lymphoblastic Leukemia

Drugs mentioned

• Inotuzumab ozogamicin (inotuzumab ozogamicin)

Snippet

Sponsor: Nicola Goekbuget | Conditions: Precursor Cell Lymphoblastic Leukemia | Phase 2 | Status: UNKNOWN